Read More

Arrowhead Pharmaceuticals Earns $50M Milestone From Royalty Pharma, Pursuant To Its 2016 Agreement With Amgen And 2022 Agreement With Royalty Pharma, Arrowhead Is Further Eligible To Receive Up To An Additional $375M From Amgen And $110M From Royalty P…

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced a $50 million milestone payment was received from Royalty Pharma plc (NASDAQ:RPRX). This milestone was triggered after the completion of enrollment of the

AMGN

Read More

Kline Hill Invests In Complete Solaria With Debt-Equity Swap, And An Additional Cash Investment; Complete Solaria Will Issue 9.8M Shares Of Outstanding Stock To KHP In Return For Cancelling Its Debt; Kline Hill Also Agreed To Buy 3.7M Complete Solaria…

Complete Solaria, Inc. ("Complete Solaria" or the "Company") (NASDAQ:CSLR) today announced that Kline Hill Partners (KHP), a Complete Solaria debt holder, has agreed to a debt-for-equity swap, and an additional cash

CSLR